Antibiotic resistance in the Middle East and Southern Asia: a systematic review and meta-analysis
JAC-Antimicrobial Resistance · 26.12.2024 · 7 (1)
DOI: 10.1093/jacamr/dlaf010 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JAC-Antimicrobial Resistance, online erschienen am 19.02.2025. Verfasst von Rachel Mathu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Médecins Sans Frontières, New York, USA. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 236 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Médecins Sans Frontières, Médecins Sans Frontières-USA office.
Abstract (Originalsprache)
Introduction
Despite global surveillance efforts, antibiotic resistance (ABR) is difficult to address in low- and middle-income countries (LMICs). In the absence of country-wide ABR surveillance data, peer-reviewed literature is the next most significant source of publicly available ABR data. Médecins Sans Frontières conducted this review in hopes of using the pooled findings to inform treatment choices in the studied countries where sufficient local ABR data are unavailable.
Methods
A systematic literature review reporting ABR rates for six infection sites in nine countries in the Middle East and Southern Asia was conducted. PubMed was used to identify literature published between January 2012 and August 2022. A meta-analysis of the included studies (n = 694) was conducted, of which 224 are reviewed in this paper. The JBI critical appraisal tool was used to evaluate risk of bias for included studies.
Results
This paper focuses on sepsis, burns and wound infections, specifically, with the largest number of papers describing data from Iran, Türkiye and Pakistan. High (>30%) resistance to recommended first-line antibiotics was found. Gram-negative resistance to ceftriaxone, aminoglycosides and carbapenems was high in burn-related infections; colistin resistance among Klebsiella pneumoniae isolates in Pakistan was alarmingly high (81%).
Conclusions
High-quality data on ABR in LMIC settings remain difficult to obtain. While peer-reviewed literature is a source of publicly available ABR data, it is of inconsistent quality; the field also lacks agreed reporting standards, limiting the capacity to pool findings. Nonetheless, high resistance to first-line antibiotics underscores the need for improved localized surveillance and stewardship.
Autor:innen und Institutionen
- Médecins Sans Frontières, New York, USA.
- Barcelona Institute for Global Health, PR3 Hub, Barcelona, Barcelona, Spain.
- Department of Intervention Epidemiology and Training, Epicentre, Paris, France.
- Médecins Sans Frontières, Paris, France.
Förderung
- Médecins Sans Frontières
- Médecins Sans Frontières-USA office
Zitieren
APA
Mathu, R., Diago-Navarro, E., Lynch, E., Degail, M. A., Ousley, J., Kanapathipillai, R., Michel, J., Gastellu-Etchegorry, M., & Malou, N. (2024). Antibiotic resistance in the Middle East and Southern Asia: a systematic review and meta-analysis. JAC-Antimicrobial Resistance, 7(1). https://doi.org/10.1093/jacamr/dlaf010
Vancouver
Mathu R, Diago-Navarro E, Lynch E, Degail MA, Ousley J, Kanapathipillai R, et al. Antibiotic resistance in the Middle East and Southern Asia: a systematic review and meta-analysis. JAC-Antimicrobial Resistance. 2024;7(1). doi:10.1093/jacamr/dlaf010
BibTeX
@article{Mathu2024,
author = {Mathu, Rachel and Diago-Navarro, Elizabeth and Lynch, Emily and Degail, Marie-Amélie and Ousley, Janet and Kanapathipillai, Rupa and Michel, Justine and Gastellu-Etchegorry, Marc and Malou, Nada},
title = {Antibiotic resistance in the Middle East and Southern Asia: a systematic review and meta-analysis},
journal = {JAC-Antimicrobial Resistance},
year = {2024},
volume = {7},
number = {1},
doi = {10.1093/jacamr/dlaf010}
}
EUVIMED